Conversion of Vaccines from Low to High Immunogenicity by Antibodies with Epitope Complementarity

Researchers leveraged in vivo systems that allowed precise control of antigen-specific antibodies (Abs) and B cells to examine the impact of Ab dose, affinity, and specificity in directing B cell activation and differentiation.